Outcome of NHS England consultation, ‘Items which should not be routinely prescribed in primary care’
At their Board meeting on 30 November 2017, NHS England has published the findings of the public consultation entitled ‘Items which should not be routinely prescribed in primary care’. Views were sought between July and October 2017 on proposals to limit the prescription of 18 products costing a total of £141million per year, which it was felt should not be routinely prescribed in primary care. The consultation also sought views on potentially limiting the prescribing of medicines that are available over the counter.
Many recommendations remain the same, however, there have been important refinements and clarifications made in respect of the following items which have been recommended for blacklisting:
- Glucosamine and Chondroitin
- Herbal Treatments
- Lutein and Antioxidants
- Omega-3 Fatty Acid Compounds
- Rubefacients (excluding topical NSAIDS)
A further formal consultation will take place if a decision is made to proceed with any recommendation.
Regarding over the counter items not being routinely prescribed in primary care, the Board “believe that it is appropriate for NHS England to work with partners to develop formal and far more detailed guidance to CCGs”. It is proposed that draft guidance be published in 2018 subject to NHS England Board approval.